Navigation Links
Soflens66 Toric

ProductsSoflens66 Toric
Company Bausch & Lomb Storz
Item Soflens66 Toric
Features Daily wear. Extended wear up to 7 days. High water. High oxygen permeability. Cast molded. Visibility tint
Description SofLens66 Toric lens are fit for all astigmatic patients. Ideal for current soft toric lens wearers who require excellent visual acuity and comfort with the health and convenience of disposable lenses; astigmatic spectacle wearers who want the convenience of contact lenses; and spherically masked astigmatic patients looking for better visual acuity.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000
Web site: http://www.storz.com/

Related medicine products :

1. Acuvue Toric
2. Optima Toric
3. Vertex Toric®
4. Frequency® 55 Toric
5. Frequency® 55 Toric XR
6. Hydrasoft® Toric
7. Preference® Toric
8. Proclear® Toric
9. Proclear® Tailor Made Toric
10. Focus Dailies Toric
11. Focus Toric Monthly lenses
StreamLAB combines consolidated analytical testing of Dimension Systems with pre- and post-analytical functions to provide an innovative laboratory automation solution "REAL-ized" for the needs of to
Roche OMNI S is the next generation Critical Care Analyzer completes and extends the Roche product portfolio for Hospital Point of Care applications. The modular concept allows to customize the compr
Mini-flatbed agitator.
...range of storage capacities. Delrin rollers and gl...smoothly, eliminating the need for ball bearings w...rated drawers with non-slip textured coating provi...,i.Series platelet agitators feature a built-in ...
Medicine Products:
(Date:7/25/2008)...Authority offers patients consumers tips and encou...t safety, HARRISBURG, Pa., July 25 /PRNewswire-US...rity today supports "National Patient Safety Day" ...nd their families to,participate fully in their he...ng they can about their surgery or illness., "We ...
(Date:7/25/2008)...vanCotter Releases Results of Fourth Annual Physic...rvey, DETROIT, July 25 /PRNewswire/ -- Sullivan, ...th annual survey of physician on-call pay rates an... Report. The survey report,with data from 132 hea...an,on-call pay practices and rates paid for 33 phy...
(Date:7/25/2008)...d Relationship Based on Significant Improvements i...-- MDdatacor, Inc., a leader in health,care qualit...ers, today,announced it has entered into a long-te...pport Wellmark,s Collaboration on Quality(SM) Ince...ration between Wellmark and,primary care clinician...
(Date:7/25/2008)...TON, July 25 /PRNewswire/ -- The Elekta Family of ...r treatment solutions at the 2008,American Associa...ng,demonstrating how the joint forces of Elekta, ...n therapy planning and delivery solutions that,str...xperience for,patients, as well as enhance clinici...
Breaking Medicine News(10 mins):Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3
...thod of treating childhood brain tumours, aimed at...to be trialled at hospitals around the US. Researc...blastoma – the most common malignant childhood bra...ower radiation and increased chemotherapy doses th...
...only used in vitro fertilisation (IVF) technique i...e the risk of babies being born with abnormalities... Pasteur Institute in Paris, France, say that men ...ther, more serious genetic faults that can be pass...
...g to a new study infants born during the night hav...h than those born during the day. There is also a ... which may be partly explained by hospital staff s...ours between 5pm and 1am are high risk periods for...
...ng drugs via nasal spray might overcome a major ob...according to researchers.Based on early studies in...er's Research Center in St. Paul, Minnesota, repor...nā€ could breach the blood-brain barrier, which pro...
Other Medicine News:Health News:Nasal Spray Could Take Drugs Directly to Brain 2
(Date:7/24/2008)...NTAIN VIEW, Calif., July 24 /PRNewswire-FirstCall/...announced today that it has initiated,its second P...apine).,AZ-004 is an inhalation product candidate ...on in patients with schizophrenia or bipolar disor...e and rapid pharmacokinetic,(PK) properties result...
(Date:7/24/2008)...HINGTON, July 24 /PRNewswire-USNewswire/ -- Headli...ot tell the whole story. The small scale,prelimin...e in Human,Reproduction, is based on recollected i...ning soyfoods. "This study is confounded by many,i...th a great deal of,caution," warned Dr. Tammy Hedl...
(Date:7/24/2008)...olutionary thermometer designed to take body tempe...July 24 /-- Kidz-Med, Inc.,...Pink Sheets: ASFX),United States distributor of t...is pleased to announce the results of a clinical s...the University of Milan, in,Milan, Italy, which pr...
(Date:7/24/2008)...HIA ANTIPOLIS, France, July 24 /PRNewswire-FirstCa...unced the top-line results from the 52-week,open l... the completion of,the 301 phase 3 study for napro...findings and efficacy was maintained for the one-y...ents, global assessment scale. In,addition, the re...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Soyfoods Do Not Impact Sperm Count 2Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill 2155 1AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill 2155 2Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless States SafeMinds 398 1Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless States SafeMinds 398 2ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 1ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 2ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 3ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 4ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments 2151 5TriWest On Deck to Support Fleet Week San Diego 2148 1TriWest On Deck to Support Fleet Week San Diego 2148 2